Polyacrylic Acid Macromolecular Crowders for 3D Tissue Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing three-dimensional tissue substitutes are inefficient, requiring large numbers of cells and prolonged culture times, leading to cell phenotype loss and limited clinical translation, and lack the ability to produce thick, functional tissue constructs quickly and cost-effectively.
Innovation Solution
A method using polyacrylic acid as a macromolecular crowder in combination with temperature-sensitive electrospun scaffolds to accelerate extracellular matrix synthesis and deposition, allowing for the rapid production of thick, functional three-dimensional tissue substitutes with reduced cell requirements and shorter culture times.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If traditional two-step cell sheet layering method is used to produce 3D tissue, then tissue thickness can be increased, but culture time is prolonged and cell phenotype is lost
Solution Approach 1:
The invention changes the chemical composition parameter of the culture medium by adding macromolecular crowders (such as Ficoll, dextran, or polyethylene glycol) at concentrations of 5-500 mg/mL. This parameter change accelerates ECM synthesis and deposition rates, enabling thick tissue constructs (several hundred micrometers) to be produced within 7-14 days while maintaining cell phenotype, compared to traditional methods requiring weeks to months.
2Volume of moving object
If traditional cell sheet layering is used to produce thick tissue, then tissue thickness increases, but manufacturing complexity increases due to multiple operations
Solution Approach 1:
The invention merges multiple separate cell sheet layering operations into a single continuous culture process. By incorporating macromolecular crowders into the culture medium, the system enables simultaneous ECM synthesis and tissue thickening in one step, eliminating the need for repeated detachment, layering, and reculturing operations that characterize traditional methods.
3Productivity
If large numbers of cells are used to produce thick tissue quickly, then productivity increases, but cell availability becomes limited for autologous applications
Solution Approach 1:
The invention changes the culture medium composition by adding macromolecular crowders that accelerate biochemical reactions and ECM deposition. This enables high productivity (thick tissue in 7-14 days) using reduced cell numbers (50,000-100,000 cells/cm²), making autologous applications feasible where patient cell availability is limited.
4Quantity of substance
If prolonged culture time is used to produce sufficient ECM, then ECM quantity increases, but cell phenotype is lost
Solution Approach 1:
The invention changes the culture medium composition by incorporating macromolecular crowders (Ficoll, dextran, or polyethylene glycol) at 5-500 mg/mL concentrations. This parameter change accelerates ECM synthesis and deposition rates by several-fold, enabling sufficient ECM quantity to be achieved within 7-14 days while maintaining cell phenotype stability, whereas traditional methods require weeks to months and result in phenotype loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of thick, functional three-dimensional tissue substitutes within a fraction of the time and cell numbers required by traditional methods, promoting accelerated wound healing and reduced scar formation, while maintaining cellular phenotype and function.
Implementation Method 1
the concept of macromolecular crowding (MMC) has been introduced that, following the principles of excluded volume effect, accelerates biochemical reactions and biological processes by several orders of magnitude
Implementation Method 2
surfaces coated with temperature-responsive polymers, which upon reduction of the temperature below the lower critical solution temperature (LCST) of the polymer allow for the detachment of intact cells and deposited ECM thin layers
Data Source
AI summary
Accelerated development of functional three-dimensional tissue moduli. The present invention relates to a process for the production of two and three-dimensional tissues and to tissues produced by the method. The present invention further relates to a process for tissue production using polyacrylic acid as a macromolecular crowder and to tissues produced by the method.